Figure 1.
Kaplan-Meier curves of the (A) progression-free and (B) overall survival of patients treated with pemetrexed, gefitinib, and erlotinib.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.